Chinese API manufacturer receives FDA warning letter after QC employee says test results 'in my mind'
The FDA last week sent a warning letter to China-based Sichuan Deebio Pharmaceutical after a September inspection led to data integrity and other quality control …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.